Member Info for alcatrazz

spread closing - bid increasing

we shall see - yes years ago but this traded at 12p a share

anything over 3k going to negotiated trades

The Company confirms today that the renewal of its Drug Production Permit ("DPP") has been granted ahead of the previously advised timescales. The Company understands that the processing of the DPP application was accelerated following a number of representations by the Company's management to Shaanxi Provincial Food and Drug Administration. The new DPP remains in force until 31 December 2020. As the Company now has the DPP and the Good Manufacturing Practice ("GMP") certificate, the regulatory restrictions on the Company's manufacture and sale of Homoharringtonine and its Traditional Chinese Medicine ("TCM") products have now been lifted. The Company does not anticipate that this short delay will have had any impact on the Company's businesses.

BID up to 2.5

ask increasing

better year and about to turn IMHO - COULD BE AT BOTTOM AT PRESENT Outlook The Company spent much of 2015 concentrating on the re-application for Chinese GMP certification. As previously announced, this has been achieved. This, combined with the renewal of the Company's Drug Production Permit means that there are no regulatory barriers to the expansion of the Company's TCM (including Bian Tong Pian) and Homoharringtonine sales. The Company intends to spend much of 2016 in leveraging the re-certification, paying particular attention to recovering market share in Homoharringtonine and in expanding its distribution of Bain Tong Pian. The sales of both of these products have been severely constrained by the unstable GMP environment which has now come to an end.

not many shares - 2k going to negotiated trade

got in this morning hoping for a nice afternoon

2.58 to buy now

well in now lets see where it goes

1st quote 2.47 to buy

wont do a negotiated trade ever

cant get in yet

negotiated trades to buy lol

thats some jump

up she goes

share rising again

March 21, 2016 Tethys Petroleum Limited Press Release: Olisol Converts Debt into Tethys Ordinary Shares at US$0.10 GRAND CAYMAN, CAYMAN ISLANDS--(Marketwired - March 21, 2016) - (TSX:TPL)(LSE:TPL) NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO US NEWSWIRE SERVICES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF SUCH JURISDICTIONS. THE OFFERS AND SALES OF SECURITIES REFERRED TO BELOW HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION UNDER THE SECURITIES ACT OR AN EXEMPTION FROM SUCH REGISTRATION. Tethys Petroleum Limited ("Tethys" or the "Company") today announces that under the terms of the previously announced Facility Agreement Amendment, it has received a signed conversion notice from Olisol Petroleum Limited ("Olisol") to convert US$6,304,446 of its outstanding debt into 63,044,460 shares in Tethys at a price of US$0.10 ("Interim Facility Conversion"). The 5-day volume weighted average price of shares in Tethys was CDN$0.04 (US$0.03). Pursuant to applicable rules of the Toronto Stock Exchange ("TSX"), Olisol may not become a 10% or more shareholder of the Company until the TSX has approved Personal Information Forms ("PIFs") submitted by Olisol. As such, Olisol have today converted US$3,744,004.20 of the loan into 37,440,042 shares, which is the maximum amount they are able to convert and remain below a 10% shareholding. Olisol have now filed their PIFs with the TSX which once approved will allow them to convert the remaining US$2,560,441.90 of the debt into a further 25,604,419 shares at a price of US$0.10. This combined with today's conversion, will result in Olisol owning approximately 15.8% of the enlarged undiluted share capital of the Company. Tethys and Olisol are also currently negotiating an Investment Agreement whereby Olisol has committed to purchasing 181,240,793 new Tethys shares at a price to be agreed by Tethys and Olisol (acting reasonably). This potential purchase, together with the Interim Facility Conversion would result in Olisol owning approximately 42% of the enlarged undiluted share capital of the Company. About Tethys Tethys is focused on oil and gas exploration and production activities in Central Asia and the Caspian Region. This highly prolific oil and gas area is rapidly developing and Tethys believes that significant potential exists in both exploration and in discovered deposits. About Olisol Olisol and its subsidiaries and affiliates have investments in energy and oil and gas operations in the Russian Federation and Kazakhstan. The company has more than seven years of experience with Tethys in Kazakhstan and owns the Aral Oil Terminal in partnership with Tethys. Olisol

tops leaderboard